Age-related Disease: A Revolution Is Coming

Jeffrey S Bland, PhD

We are starting to develop the analytical tools to examine damage to our DNA and screen for the presence of clonal hematopoiesis of indeterminate potential. This type of technology will soon support the personalization of approaches to both the prevention and treatment of age-related diseases, which have historically been characterized as beyond our control. We are at the start of an era that will one day be looked upon as the age of precision personalized lifestyle health care. This article is the first in a series in which I will be examining new tools and research that I believe is paving the path forward and leading to exciting times ahead.

I am a subscriber to IMCJ and would like to read this article
I would like to purchase this article - $35.00
I would like to subscribe to IMCJ for $55.00 and obtain access to this article